Annual Working Capital
$600.94 M
+$72.88 M+13.80%
31 December 2023
Summary:
Verve Therapeutics annual working capital is currently $600.94 million, with the most recent change of +$72.88 million (+13.80%) on 31 December 2023. During the last 3 years, it has risen by +$534.29 million (+801.63%). VERV annual working capital is now at all-time high.VERV Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$513.82 M
-$36.70 M-6.67%
30 September 2024
Summary:
Verve Therapeutics quarterly working capital is currently $513.82 million, with the most recent change of -$36.70 million (-6.67%) on 30 September 2024. Over the past year, it has increased by +$50.13 million (+10.81%). VERV quarterly working capital is now -14.50% below its all-time high of $600.94 million, reached on 31 December 2023.VERV Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VERV Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +13.8% | +10.8% |
| 3 y3 years | +801.6% | +37.3% |
| 5 y5 years | - | - |
VERV Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +801.6% | -14.5% | +88.3% |
| 5 y | 5 years | at high | +3776.8% | -14.5% | +670.9% |
| alltime | all time | at high | +3776.8% | -14.5% | +670.9% |
Verve Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $513.82 M(-6.7%) |
| June 2024 | - | $550.52 M(-6.5%) |
| Mar 2024 | - | $589.03 M(-2.0%) |
| Dec 2023 | $600.94 M(+13.8%) | $600.94 M(+29.6%) |
| Sept 2023 | - | $463.69 M(+5.4%) |
| June 2023 | - | $440.04 M(-9.1%) |
| Mar 2023 | - | $484.24 M(-8.3%) |
| Dec 2022 | $528.06 M | $528.06 M(-0.9%) |
| Sept 2022 | - | $532.61 M(+95.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $272.80 M(-13.1%) |
| Mar 2022 | - | $314.03 M(-9.0%) |
| Dec 2021 | $345.10 M(+417.8%) | $345.10 M(-7.8%) |
| Sept 2021 | - | $374.19 M(-8.9%) |
| June 2021 | - | $410.92 M(+183.1%) |
| Mar 2021 | - | $145.16 M(+117.8%) |
| Dec 2020 | $66.65 M(+330.0%) | - |
| Dec 2020 | - | $66.65 M |
| Dec 2019 | $15.50 M | - |
FAQ
- What is Verve Therapeutics annual working capital?
- What is the all time high annual working capital for Verve Therapeutics?
- What is Verve Therapeutics annual working capital year-on-year change?
- What is Verve Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Verve Therapeutics?
- What is Verve Therapeutics quarterly working capital year-on-year change?
What is Verve Therapeutics annual working capital?
The current annual working capital of VERV is $600.94 M
What is the all time high annual working capital for Verve Therapeutics?
Verve Therapeutics all-time high annual working capital is $600.94 M
What is Verve Therapeutics annual working capital year-on-year change?
Over the past year, VERV annual working capital has changed by +$72.88 M (+13.80%)
What is Verve Therapeutics quarterly working capital?
The current quarterly working capital of VERV is $513.82 M
What is the all time high quarterly working capital for Verve Therapeutics?
Verve Therapeutics all-time high quarterly working capital is $600.94 M
What is Verve Therapeutics quarterly working capital year-on-year change?
Over the past year, VERV quarterly working capital has changed by +$50.13 M (+10.81%)